Cranbrook Wealth Management’s Organon & Co OGN Stock Holding History

Cranbrook Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29K	Hold	169	–	–	﹤0.01%	374
2026 Q1	$1.01K	Hold	169	–	–	﹤0.01%	371
2025 Q4	$1.21K	Hold	169	–	–	﹤0.01%	386
2025 Q3	$1.8K	Hold	169	–	–	﹤0.01%	371
2025 Q2	$1.64K	Sell	169 -10	-6%	-$103	﹤0.01%	375
2025 Q1	$2.67K	Sell	179 -1	-0.6%	-$15	﹤0.01%	357
2024 Q4	$2.69K	Hold	180	–	–	﹤0.01%	337
2024 Q3	$3.44K	Buy	180 +1	+0.6%	+$21	﹤0.01%	314
2024 Q2	$3.71K	Hold	179	–	–	﹤0.01%	279
2024 Q1	$3.37K	Hold	179	–	–	﹤0.01%	263
2023 Q4	$2.58K	Buy	179 +10	+6%	+$136	﹤0.01%	277
2023 Q3	$2.93K	Sell	169 -16	-9%	-$334	﹤0.01%	265
2023 Q2	$3.85K	Hold	185	–	–	﹤0.01%	260
2023 Q1	$4.35K	Hold	185	–	–	﹤0.01%	261
2022 Q4	$5.17K	Hold	185	–	–	﹤0.01%	248
2022 Q3	$4K	Hold	185	–	–	﹤0.01%	276
2022 Q2	$6K	Hold	185	–	–	﹤0.01%	264
2022 Q1	$7K	Hold	185	–	–	﹤0.01%	293
2021 Q4	$6K	Hold	185	–	–	﹤0.01%	315
2021 Q3	$6K	Hold	185	–	–	﹤0.01%	327
2021 Q2	$6K	Buy	+185	New	+$6.09K	﹤0.01%	304

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Cranbrook Wealth Management's OGN Position: Q2 2026 in Review

Cranbrook Wealth Management held its Organon & Co (OGN) position steady in Q2 2026 at 169 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #374.

Cranbrook Wealth Management first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $7K in Q1 2022. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Cranbrook Wealth Management held 169 shares of Organon & Co worth $2.29K as of Q2 2026.
Cranbrook Wealth Management left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q2 2026, its #374 holding.
Cranbrook Wealth Management first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
Cranbrook Wealth Management's Organon & Co position peaked at $7K in Q1 2022.
635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.